Shih Chia Lin

Shih Chia Lin currently works at Foundation of Medical Professionals Alliance In Taiwan, as Chief Executive Officer, TSC Bioventure Capital Corp., as Director, TaiMed Biologics, Inc., as Director, SynCore Biotechnology Co., Ltd., as Director from 2018, Peng Wan-Ru Foundation, as Director, Locus Cell Co., Ltd., as Director from 2021, and Tripartite Therapeutics, Inc., as Director from 2025.
Ms. Lin also formerly worked at Bora Pharmaceuticals Co., Ltd., as Director and UBI Pharma Inc., as Director.
Ms. Lin received her undergraduate degree from National Taiwan University and graduate degree from National Yang Ming University.